Related Experiment Video
Updated: Aug 17, 2026

A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels
Published on: April 24, 2012
Tetrabutylammonium: a selective blocker of the somatostatin-activated hyperpolarizing current in mouse AtT-20
1Department of Pharmacology, University of Cambridge, United Kingdom. pjt28@cam.ac.uk
Abstract:
To obtain a clearer understanding of the mechanisms by which somatostatin modulates stimulus-secretion coupling in neuroendocrine cells, we investigated the pharmacology of the somatostatin-activated inward rectifier in mouse pituitary tumour cells (AtT-20 corticotrophs). Individual AtT-20 cells displayed spontaneous, long-lasting action potentials that caused transient spikes in cytosolic [Ca2+] ([Ca]i). Application of 1-10 nM somatostatin led to membrane hyperpolarization and loss of [Ca]i spiking activity. Voltage-clamp recordings revealed that the somatostatin-induced hyperpolarization was due to an inwardly rectifying K+ current. Tetrabutyl-ammonium (TBA+) inhibited both outward and inward currents through the inward rectifier, whereas Cs+ blocked only inward current and tetraethylammonium (TEA+) was completely ineffective in blocking somatostatin-activated currents. However TEA+, but neither TBA+ nor Cs+, blocked voltage-gated outward currents. Correspondingly, TBA+ abolished the hyperpolarizing effects of somatostatin and, of the three K+ channel blockers, only TBA+ prevented the somatostatin-induced inhibition of [Ca]i spiking. TBA+ may thus prove a useful tool in elucidating the underlying mechanisms by which somatostatin affects the secretory activity of neuroendocrine cells.
Insights
Somatostatin inhibits neuroendocrine cell activity by activating an inward rectifier potassium current. Tetrabutyl-ammonium (TBA+) specifically blocks this effect, revealing its role in somatostatin
Area of Science:
- Neuroendocrinology
- Cellular Physiology
- Pharmacology
Background:
- Neuroendocrine cells regulate essential bodily functions through stimulus-secretion coupling.
- Somatostatin is a key hormone modulating these processes, but its precise mechanisms remain incompletely understood.
- Understanding somatostatin's action on ion channels is crucial for deciphering its physiological roles.
Purpose of the Study:
- To investigate the pharmacological properties of the somatostatin-activated inward rectifier potassium current.
- To elucidate the role of this specific ion channel in somatostatin's modulation of stimulus-secretion coupling in AtT-20 corticotrophs.
Main Methods:
- Utilized voltage-clamp recordings in mouse pituitary tumour cells (AtT-20 corticotrophs).
- Examined the effects of somatostatin on membrane potential and cytosolic calcium ([Ca2+]) dynamics.
- Tested the inhibitory effects of potassium channel blockers: tetrabutyl-ammonium (TBA+), cesium (Cs+), and tetraethyl-ammonium (TEA+).
Main Results:
- Somatostatin induced membrane hyperpolarization and suppressed calcium spiking by activating an inward rectifier potassium current.
- Tetrabutyl-ammonium (TBA+) selectively blocked the somatostatin-activated current and its inhibitory effects on calcium spiking.
- Cesium (Cs+) partially blocked the inward current, while tetraethyl-ammonium (TEA+) was ineffective on the somatostatin-activated current but blocked voltage-gated outward currents.
Conclusions:
- The somatostatin-activated inward rectifier potassium current plays a critical role in inhibiting neuroendocrine cell secretory activity.
- Tetrabutyl-ammonium (TBA+) is a valuable pharmacological tool for dissecting the mechanisms of somatostatin action.
- These findings provide insights into how somatostatin regulates stimulus-secretion coupling in neuroendocrine cells.
More Related Videos
08:30Preparation and Utilization of Freshly Isolated Human Detrusor Smooth Muscle Cells for Characterization of 9-Phenanthrol-Sensitive Cation Currents
Published on: January 31, 2020
06:57Intramuscular Transplantation of Human Pluripotent Stem Cell-derived Pancreatic Endocrine Cells in Mice
Published on: April 10, 2026
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Blockers
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics